Bank Of New York Mellon Corp Imara Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.73 - $5.2 $194,060 - $270,540	52,027 New	52,027 $212,000
Q2 2022 Aug 15, 2022	SELL	$0.99 - $1.87 $17,100 - $32,300	-17,273 Reduced 24.78%	52,419 $64,000
Q1 2022 May 11, 2022	BUY	$1.15 - $2.41 $58,685 - $122,984	51,031 Added 273.46%	69,692 $131,000
Q3 2021 Nov 12, 2021	BUY	$4.08 - $7.83 $2,088 - $4,008	512 Added 2.82%	18,661 $76,000
Q1 2021 May 13, 2021	SELL	$8.18 - $23.98 $66,830 - $195,916	-8,170 Reduced 31.04%	18,149 $153,000
Q4 2020 Feb 09, 2021	BUY	$15.81 - $29.0 $188,534 - $345,825	11,925 Added 82.85%	26,319 $580,000
Q3 2020 Nov 12, 2020	SELL	$18.75 - $28.58 $15,543 - $23,692	-829 Reduced 5.45%	14,394 $292,000
Q2 2020 Aug 12, 2020	BUY	$15.6 - $54.87 $237,478 - $835,286	15,223 New	15,223 $420,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.